Canada: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Canada's Drug Agency Announces Consultation On Streamlined Review Process And New Reconsideration/resubmission Procedures

On January 29, 2026, Canada's Drug Agency (CDA) published Improvements to the Drug Reimbursement Review Process, which includes a section for consultation on proposed changes to the reimbursement review process.

Canada Healthcare

SB

Smart & Biggar

Canadian Product Stewardship And EPR: A Review Of 2025 And Beyond

In 2025, Canadian governments and producer‑responsibility organizations ("PROs") continued advancing innovative product stewardship and extended producer responsibility...

Canada Environment

GW

Gowling WLG

New PMPRB Chairperson And PMPRB Releases January 2026 NEWSletter

On January 29, 2026, the Minister of Health announced Anie Perrault, former Vice-Chairperson, as Chairperson of the Patented Medicine Prices Review Board (PMPRB) until August 9, 2028.

Canada Healthcare

SB

Smart & Biggar

Nouvelle présidente au CEPMB et publication de l'édition de janvier 2026 de la Nouvelle du CEPMB

Le 29 janvier 2026, la ministre de la Santé a a annoncé la nomination d'Anie Perrault, ancienne vice-présidente...

SB

Smart & Biggar

Legislative Update Report No. 2026-04 Le Bulletin D'actualités Législatives

Canada Government

OH

Osler, Hoskin & Harcourt LLP

Ce Que Les Organismes De Santé Doivent Savoir Sur Les Nouvelles Directives Entourant La Transcription Par IA En Ontario, En Colombie-Britannique Et En Alberta

Canada Technology

BL

Borden Ladner Gervais LLP

Health Canada Introduces New Efforts To Expedite Review Of Drug Submissions

Canada Healthcare

TL

Torys LLP

Proposed Ministerial Reliance Order Would Allow Health Canada To Rely On Decisions Of Foreign Trusted Regulators

Canada Healthcare

SB

Smart & Biggar

Revue de l'année 2025 en droit des brevets au Canada

SB

Smart & Biggar

Les 10 articles incontournables de la Mise à jour en PI Rx en 2025

Canada Healthcare

SB

Smart & Biggar

Zero-Rated Or Taxable Food & Drinks?

MK

Millar Kreklewetz

Canadian Trademark Law Year In Review 2025: Notable Decisions And Updates

C

Cassels

The Canada Mutual Recognition Agreement – A Two-Way Street To The Market

FR

Fillmore Riley

Double brevet et demandes divisionnaires au Canada : des stratégies évolutives pour les demandeurs

SB

Smart & Biggar

AI Washing: The New Greenwashing — How The SEC's Emerging Technologies Unit Is Rewriting The Compliance Landscape

Canada Technology

ML

McMillan LLP

The Rise Of AI Scribes: Balancing Efficiency With Privacy In Canadian Health Care

Canada Technology

AB

Aird & Berlis LLP

Workplace Culture As An Excuse: Can A "Racist Culture" Be A Mitigating Factor?

Canada Employment

RT

Rubin Thomlinson LLP

From Excess To Discipline To Scarcity: What Allied Gold's 27% Premium Tells Us About The Next Phase Of Gold M&A

Canada Commercial

GW

Gowling WLG

Canadian Federal Government Releases Hybrid Mismatch And Other Draft Tax Amendments

OH

Osler, Hoskin & Harcourt LLP

Service Of Process: More Than A Formality

Plaintiffs usually start lawsuits by serving the defendant personally with a statement of claim. While personal service is the "gold standard," Ontario's Rules of Civil Procedure permit alternative...

Canada Litigation

C

Cassels

2025 Highlights In Canadian Life Sciences IP And Regulatory Law

In September, we provided our eighth annual update following the significant September 2017 amendments to the PM(NOC) Regulations.

Canada Healthcare

SB

Smart & Biggar

Les faits saillants de 2025 au Canada en matière de PI en sciences de la vie et de droit réglementaire

En 2025, l'équipe responsable des mises à jour PI Rx chez Smart & Biggar s'est penchée sur un certain nombre de nouveautés en matière de PI en sciences de la vie et de droit réglementaire.

Canada Healthcare

SB

Smart & Biggar

2025 Highlights In Canadian Life Sciences IP And Regulatory Law

In 2025, the Rx IP Update team at Smart & Biggar reported on a number of developments in Canadian life sciences IP and regulatory law. Highlights from 2025 are below.

Canada Healthcare

SB

Smart & Biggar

Class Action Pursued Concerning Safety Defects With GLP-1 Drugs Mounjaro, Trulicity, & Zepbound

Canada Litigation

SL

Siskinds LLP

Federal Court Of Appeal Confirms BYOOVIZ Is Confusing With Novartis' BEOVU Trademark

SB

Smart & Biggar

Santé Canada lance une consultation sur deux documents d'ébauche de lignes directrices sur les conditions pour les médicaments à usage humain et vétérinaire ainsi que les présentations de drogues basées sur des preuves prometteuses d'efficacité clinique

Canada Healthcare

SB

Smart & Biggar

Proposal For Modernizing Clinical Trial Framework Aims To Improve Access To New And Innovative Therapies In Canada

Canada Healthcare

SB

Smart & Biggar

Une proposition de modernisation du cadre des essais cliniques pour favoriser l'accès à de nouvelles thérapies innovantes au Canada

Canada Healthcare

SB

Smart & Biggar

Cancer-linked Drug And Product Lawsuits: Legal Pathways For Affected Patients

Canada Healthcare

SL

Siskinds LLP

Legislative Update Report No. 2025-24 Le Bulletin D'actualités Législatives

Canada Government

OH

Osler, Hoskin & Harcourt LLP

Naming Natural Health Products: Branding In A Grey Zone

Canada Healthcare

ML

McMillan LLP

Liability Of Police Chiefs & Police Boards For Officer Misconduct: Rivard V. Ontario, 2025 ONCA 100

Canada Litigation

AH

Alexander Holburn Beaudin + Lang LLP

Health Canada Consultation On Two Draft Guidance Documents On Terms And Conditions For Human And Veterinary Drugs And Drug Submissions Based On Promising Evidence Of Clinical Efficacy

Canada Healthcare

SB

Smart & Biggar

Legislative Update Report No. 2025-24 Le Bulletin D'actualités Législatives

Osler's Legislative Update is a bi-weekly listing of new legislation. This issue covers legislation for the period 12/12 to 12/24.

Canada Government

OH

Osler, Hoskin & Harcourt LLP

Naming Natural Health Products: Branding In A Grey Zone

Over the course of our previous bulletins, we have examined branding considerations for prescription drugs, over-the-counter drugs, and medical devices.

Canada Healthcare

ML

McMillan LLP

Liability Of Police Chiefs & Police Boards For Officer Misconduct: Rivard V. Ontario, 2025 ONCA 100

In Rivard v. Ontario, 2025 ONCA 100 [Rivard], the Ontario Court of Appeal considered the adequacy of a pleading against a municipal police chief and police board in respect of a negligence...

Canada Litigation

AH

Alexander Holburn Beaudin + Lang LLP

Health Canada Consultation On Two Draft Guidance Documents On Terms And Conditions For Human And Veterinary Drugs And Drug Submissions Based On Promising Evidence Of Clinical Efficacy

As previously reported, in December 2024, Health Canada published its agile licensing amendments to the Food and Drug Regulations (FDRs).

Canada Healthcare

SB

Smart & Biggar

Supreme Court Of Canada Affirms Immunity From Arrest In S.4.1(2) Of The Controlled Drugs And Substances Act

Canada Healthcare

AH

Alexander Holburn Beaudin + Lang LLP

What You Should Know About The Freestyle Libre 3 Recall

There is little doubt that medical technology has dramatically enhanced the quality and longevity of our lives. We continue to see innovations that not only aid in earlier detection of disease...

Worldwide Litigation

GP

Gluckstein Lawyers

VC Investment In Canada For Life Sciences Companies

Despite recent pullbacks in biotechnology and life sciences venture capital ("VC") funding in Canada, a more in-depth analysis reveals strong indicators of investment demand...

Canada Healthcare

MT

McCarthy Tétrault LLP

Taking Action On Food Insecurity

Once again, McMillan's Annual Giving Campaign is championing efforts to address food insecurity by contributing to five impactful organizations making a difference in our communities:

Canada Healthcare

ML

McMillan LLP

Final Patented Medicines Pricing Guidelines From The PMPRB Take Effect On January 1, 2026: What This Means For Innovative Pharma

Effective January 1, 2026, the Patented Medicine Prices Review Board (PMPRB) will implement new Guidelines for monitoring patented medicine prices in Canada.

MT

McCarthy Tétrault LLP

Canadian Patent Law In Review 2025: Notable Decisions And Updates

C

Cassels

Santé Canada et la Food and Drug Administration des États-Unis conviennent de mettre en place un programme de partage d'informations pour l'examen des médicaments génériques

Canada Healthcare

SB

Smart & Biggar

L'Agence des médicaments du Canada publie une nouvelle ressource et des données sur le processus d'autorisation et de remboursement des médicaments

Canada Healthcare

SB

Smart & Biggar

Health Canada And U.S. FDA Agree To Establish Information Sharing Program For Generic Drug Submission Reviews

Canada Healthcare

SB

Smart & Biggar

Canada's Drug Agency Releases New Resource And Data On Drug Approval And Reimbursement Pathway

SB

Smart & Biggar

Final Changes To Quebec's Exceptional Patient Measure To Come Into Effect

Canada Healthcare

F

Fasken

How To Find The Risks Linked To Your Prescriptions

Canada Healthcare

SL

Siskinds LLP

Tis The Season For Holiday Parties At Work And At Home

Canada Litigation

GP

Gluckstein Lawyers

St. Catharines v. Al-Kadhee – Closing Order Application Unburdens Community Of Problem House

Canada Real Estate

BA

Boghosian + Allen

The Rise Of Unionization In Canada: Strategies For Employers In A Post-pandemic World

Canada Employment

MT

Miller Thomson LLP

The BC Supreme Court Reinforces A Plaintiff's Duty To Exercise A Modicum Of Awareness For Their Own Safety In Petrunia v. Pensionfund Realty Limited, 2025 BCSC 2345

Canada Litigation

CC

CLC (Canadian Litigation Counsel)

L'APP lance une voie révisée pour les négociations non complexes concernant le prix de médicaments

Canada Healthcare

SB

Smart & Biggar

December 2025 Rosen Sunshine Newsletter

Canada Healthcare

RS

Rosen Sunshine LLP

L'Ontario propose de réglementer les réseaux de fournisseurs privilégiés entre assureurs et pharmacies

Canada Healthcare

BC

Blake, Cassels & Graydon LLP

L'Ontario propose des mesures législatives pour encadrer les réseaux de fournisseurs privilégiés

Canada Healthcare

SB

Smart & Biggar

See more

Latest Videos

See more

From Discovery To Market: The Role Of IP Strategy In Drug Development (Video)

GW

Gowling WLG

Pricing And Reimbursement: Federal Drug Price Control

TL

Torys LLP

Cannabis 2.0 Rollout: Edibles, Extracts Legalized (Video)

BC

Blake, Cassels & Graydon LLP

Emerging Growth And Venture Technology Video Series Part Seven: Tracking Ailments (Video)

D

Dentons Canada LLP

2018 Legal Year In Review (Video)

OH

Osler, Hoskin & Harcourt LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More